Related Experiment Video
Updated: Jun 6, 2025

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Non-combustible nicotine product cessation interventions in adolescents and young adults: A systematic review
Sofie K Bergman Rasmussen1, Charlotta Pisinger1,2
1Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark.
Abstract:
New nicotine products such as e-cigarettes, heated tobacco and smokeless tobacco/nicotine products, are popular among young people. Most regret having started using these products, but little is known about how to help adolescents and young adults to quit most effectively. This systematic review aimed to identify all existing studies on the efficacy of cessation interventions on the use of novel nicotine and tobacco products in adolescents and young adults. Original randomized controlled trials on cessation of use of e-cigarettes, heated tobacco and smokeless nicotine/tobacco products aimed at young people aged between 15 and 25 were included. The exclusion criteria were interventions on cessation of cigarette/conventional tobacco smoking and studies that focused on preventing initiation rather than cessation. Both researchers independently screened articles and extracted data. The risk of bias was assessed. A total of 345 papers were screened for eligibility, and 9 original studies were included. All studies were conducted in the United States. Populations ranged from 24 to 2588. Five studies reported significant effects of the study interventions, of which 4 were extensive multi-component smokeless tobacco cessation interventions in a high school or college setting. The fifth effective intervention was an SMS text-based e-cigarette cessation program. Low-grade evidence suggests that multi-component interventions that include counseling and an SMS text-based cessation program that is also based on behavioral support may be effective in the cessation of the use nicotine products in adolescents and young adults. Further research that includes cessation of the use of all new tobacco- and nicotine products is needed.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation